publication date: Dec. 1, 2010

In this issue: 

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions.

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research.

Paul Okunieff Named Director At UF Shands Cancer Center.

Download (PDF 492K)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.